Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|January 24, 2022
Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic StratificationYi Chen, Shuwen You, Jie Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2018
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortalityYingbo Lin, Nelly Seger, Yi Chen, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2019
An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcomaPanagiotis Tsagozis, Martin Augsten, Yifan Zhang, et al.
Cancer Reports (Hoboken, N.J.)|November 22, 2025
Oncological Outcome for 83 Consecutive Patients With Malignant Peripheral Nerve Sheath Tumors Treated at a Tertiary Referral CentreHannah V M Yeomans, Kira C Lloyd, Felix Haglund de Flon, et al.
Endocrine Pathology|June 3, 2016
Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a PatientsFelix Haglund, Stina Garvin, Catharina Ihre-Lundgren, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2021
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcomaYifan Zhang, Yi Chen, Chen Yang, et al.
Molecular and Cellular Endocrinology|October 8, 2017
Molecular profiles of oxyphilic and chief cell parathyroid adenomaMing Lu, Hanna Kjellin, Omid Fotouhi, et al.
Cancer Genetics|December 25, 2019
Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor developmentJan Köster, Elsa Arbajian, Björn Viklund, et al.
Surgery|January 12, 2017
Overexpression of cytochrome P450 2A6 in adrenocortical carcinomaTimothy D Murtha, Taylor C Brown, Jill C Rubinstein, et al.
Genes, Chromosomes & Cancer|May 9, 2019
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusionKarim H Saba, Louise Cornmark, Marianne Rissler, et al.
Pageof 9